References
- Hu F B, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence. Am J Cardiol 2002; 90: 26F–29F
- Manson J E, Hsia J, Johnson K C, Rossouw J E, Assaf A R, Lasser N L, Trevisan M, Black H R, Heckbert S R, Detrano R, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–534
- Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002; 288: 321–333
- Anderson G L, Limacher M, Assaf A R, Bassford T, Beresford S A, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial. JAMA 2004; 291: 1701–1712
- Grodstein F, Clarkson T B, Manson J E. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 2003; 348: 645–650
- Grodstein F, Manson J E, Stampfer M J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Women's Health (Larchmt) 2006; 15: 35–44
- Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219–226
- Jarrett R J, Viberti G C, Argyropoulos A, Hill R D, Mahmud U, Murrells T J. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1984; 1: 17–19
- Damsgaard E M, Frøland A, Jørgensen O D, Mogensen C E. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300: 297–300
- Yudkin J S, Forrest R D, Jackson C A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988; 2: 530–533
- Manning P J, Sutherland W H, Allum A R, de Jong S A, Jones S D. HRT does not improve urinary albumin excretion in postmenopausal diabetic women. Diabetes Res Clin Pract 2003; 60: 33–39
- Monster T B, Janssen W M, de Jong P E, de Jong-van den Berg L T. Prevention of renal and vascular end stage disease study group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med 2001; 161: 2000–2005
- Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
- Potier M, Elliot S J, Tack I. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001; 12: 241–251
- Neugarten J, Medve I, Lei J, Silbiger S R. Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. Am J Physiol 1999; 277: F875–F881
- Potier M, Karl M, Zheng F, Elliot S J, Striker G E, Striker L J. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol 2002; 160: 1877–1885